Cargando…

Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial

OBJECTIVE: To investigate effects of ulipristal acetate on health-related quality of life (QOL) and symptom severity in women with symptomatic uterine leiomyomas and abnormal uterine bleeding. METHODS: Women were randomized to ulipristal (5 mg, 10 mg) or placebo in two phase 3, multicenter, double-b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lukes, Andrea S., Soper, David, Harrington, Amanda, Sniukiene, Vilma, Mo, Yifan, Gillard, Patrick, Shulman, Lee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Contents
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485305/ https://www.ncbi.nlm.nih.gov/pubmed/30969201 http://dx.doi.org/10.1097/AOG.0000000000003211

Ejemplares similares

Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma
por: Harmon, Quaker E., et al.
Publicado: (2022)

Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas
por: Al-Hendy, Ayman, et al.
Publicado: (2022)

Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
por: Simon, James A., et al.
Publicado: (2020)

Ulipristal acetate as a treatment option for uterine fibroids
por: Piecak, Karolina, et al.
Publicado: (2017)

Successful Pregnancy after Treatment with Ulipristal Acetate for Uterine Fibroids
por: Monleón, Javier, et al.
Publicado: (2014)

Ulipristal Acetate in Adenomyosis
por: Gonçalves-Henriques, Manuel, et al.
Publicado: (2022)

Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids
por: Biglia, Nicoletta, et al.
Publicado: (2014)

Expulsion of a uterine myoma in a patient treated with ulipristal acetate
por: Chantraine, Frederic, et al.
Publicado: (2015)

Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence
por: Trefoux Bourdet, Alice, et al.
Publicado: (2015)

Safety after extended repeated use of ulipristal acetate for uterine fibroids
por: Fauser, Bart C. J. M., et al.
Publicado: (2017)

Economic impact of ulipristal acetate on surgical procedures for uterine fibroids in France
por: Fernandez, Hervé, et al.
Publicado: (2017)

Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids
por: Middelkoop, Mei-An, et al.
Publicado: (2022)

Gestational Trophoblastic Disease: Current Evaluation and Management
por: Soper, John T.
Publicado: (2021)

Health Disparities in Uterine Cancer: Report From the Uterine Cancer Evidence Review Conference
por: Whetstone, Sara, et al.
Publicado: (2022)

Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports
por: Santoro, Angela, et al.
Publicado: (2018)

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate
por: Kolterud, Åsa, et al.
Publicado: (2022)

Executive Summary of the Uterine Cancer Evidence Review Conference
por: Chelmow, David, et al.
Publicado: (2022)

Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis
por: Geale, Kirk, et al.
Publicado: (2017)

Health-Related Quality of Life Improvements in Patients With Endometriosis Treated With Elagolix
por: Taylor, Hugh S., et al.
Publicado: (2020)

World Health Organization Recommendation for Using Uterine Balloon Tamponade to Treat Postpartum Hemorrhage
por: Weeks, Andrew D., et al.
Publicado: (2022)

The use of a short course of Ulipristal Acetate for acute abnormal uterine bleeding in women without uterine fibroids
por: Lambrecht, I, et al.
Publicado: (2023)

Emergency contraception: potential role of ulipristal acetate
por: Gemzell-Danielsson, Kristina, et al.
Publicado: (2010)

Therapy with Ulipristal Acetate in a Hypertensive Patient
por: Alcalde Dominguez, A., et al.
Publicado: (2018)

The effect of ulipristal acetate treatment on symptomatic uterine fibroids within 12-months follow-up
por: Woźniak, Sławomir, et al.
Publicado: (2014)

Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate
por: Rabe, Thomas, et al.
Publicado: (2018)

Is ulipristal acetate the new drug of choice for the medical management of uterine fibroids? Res ipsa loquitur?
por: Odejinmi, Funlayo, et al.
Publicado: (2017)

Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
por: Rabe, Thomas, et al.
Publicado: (2018)

Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2020)

Markers of Inflammation and Vascular Parameters in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2021)

Symptom relief of leiomyomatosis peritonealis disseminata with ulipristal acetate
por: Verguts, Jasper, et al.
Publicado: (2013)

Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
por: Ekanem, Emmanuel, et al.
Publicado: (2020)

Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management
por: Tsoi, Bernice, et al.
Publicado: (2015)

Phase III long‐term study to evaluate the efficacy and safety of ulipristal acetate in Japanese patients with uterine fibroids
por: Osuga, Yutaka, et al.
Publicado: (2021)

Safety and efficacy of two repeated cycles of ulipristal acetate in the management of symptomatic uterine fibroid among Indian women
por: Jha, Sangam, et al.
Publicado: (2021)

Implementation of a quality and safety checklist for haemodialysis sessions
por: Marcelli, Daniele, et al.
Publicado: (2015)

Ulipristal acetate for Japanese women with symptomatic uterine fibroids: A double‐blind, randomized, phase II dose‐finding study
por: Irahara, Minoru, et al.
Publicado: (2019)

Ulipristal acetate, a progesterone receptor modulator for emergency contraception
por: Jadav, Shilpa P., et al.
Publicado: (2012)

Ulipristal Acetate in Myomectomy Optimization in an Infertile Patient with Giant Myomas
por: de la Fuente, Elena, et al.
Publicado: (2016)

Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis
por: Gatti, Milo, et al.
Publicado: (2020)

Risk–efficacy balance of ulipristal acetate compared to surgical alternatives
por: Middelkoop, Mei‐An, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j2tlhq3ptdvrhc9po1tslcihot